Artgen Biotech PJSC (MOEX: ISKJ)

Artgen Biotech PJSC Revenue

Artgen Biotech PJSC had revenue of 745.12M RUB in the half year ending June 30, 2024, with 43.32% growth. This brings the company's revenue in the last twelve months to 1.49B, up 20.55% year-over-year. In the year 2023, Artgen Biotech PJSC had annual revenue of 1.37B with 20.38% growth.

• Revenue (ttm): 1.49B
• Revenue Growth: +20.55%
• P/S Ratio: 2.95
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.29B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.37B	231.65M	20.38%
Dec 31, 2022	1.14B	-43.89M	-3.72%
Dec 31, 2021	1.18B	96.77M	8.93%
Dec 31, 2020	1.08B	248.45M	29.73%
Dec 31, 2019	835.58M	190.89M	29.61%